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What's new?
 Young adults with type 1 diabetes often disengage from clinic attendance, which may lead 
to sub-optimal glycaemic levels and an increased risk of complications. 
 We have developed a novel complex intervention, D1 Now, which focuses on promoting 
engagement of young people with clinical services. We describe the protocol for a pilot 
cluster randomized controlled trial (RCT) evaluating the D1 Now intervention in five 
diabetes centres on the island of Ireland.
 If the intervention proves feasible to deliver, we plan to proceed to a definitive RCT with 
the aim of achieving improved long-term outcomes for young adults
Abstract
Background Young adults (aged 18–25 years) living with type 1 diabetes mellitus often have sub-
optimal glycaemic levels, which can increase their risk of long-term diabetes complications. 
Informed by health psychology theory and using a  young adult-centred approach (public and 
patient involvement), we have developed a complex intervention, entitled D1 Now, to improve 
outcomes in this target group. The D1 Now intervention has three components: (1) a support 
worker; 2) an interactive messaging system; and 3) an agenda-setting tool for use during clinic 
consultations.
Aims To gather and analyse acceptability and feasibility data to allow us to (1) refine the D1 Now 
intervention, and (2) determine the feasibility of a definitive randomized controlled trial of the 
intervention. 
Methods Diabetes clinics on the island of Ireland will be recruited and randomized to a D1 Now 
intervention arm or a usual care control arm. For a participant to be eligible they should be aged 
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Results and discussion Participant outcomes (influenced by a core outcome set) include change 
in HbA1c, clinic attendance, number of episodes of severe hypoglycaemia and of diabetic 
ketoacidosis, diabetes distress, self-management, quality of life and perceived level of control over 
diabetes. These outcomes will be measured at baseline and after 12 months of follow-up for 
descriptive statistics only. An assessment of treatment fidelity, a health economic analysis and a 
qualitative sub-study will also be incorporated into the pilot study. 
(Clinical Trials registration no.: ISRCTN74114336).
Background
A growing body of evidence has shown that there is substantial variation in glycaemic levels 
among people with type 1 diabetes and there is room for improvement in all age groups, but 
especially in young adults [1]. Young adulthood is a challenging time for most, with pressures 
such as drugs, alcohol, education and changing roles and responsibilities. Living with type 1 
diabetes is a significant added burden to these existing stressors [2]. A recent systematic review 
reported that there have been relatively few trials of interventions aimed at improving outcomes 
among young adults with type 1 diabetes, and the quality of reported studies is often poor [3], 
highlighting a need for more research in this area.
This study protocol will describe a novel intervention, ‘D1 Now’, which has been developed using 
a systematic, theoretical, user-centred approach [2], the aim of which is to enhance young adults' 
ability to self-manage their type 1 diabetes and improve outcomes. The intervention targets care 
delivered in young adult diabetes (hospital) clinics. D1 Now has three components: (1) a support 
worker; (2) an interactive messaging system, 'Florence'; and (3) an agenda-setting tool. The 
development of the D1 Now intervention been described in a recent publication [2].
Central to the development of the intervention is a public and patient involvement panel, namely, 
the D1 Now Young Adult Panel. This group consists of 10 young adults living with type 1 
diabetes who participate as co-researchers in the study team. Members have contributed to all 
aspects of intervention development including reviewing study materials, abstracts, manuscripts, 
and conference presentations. The process of formation of the D1 Now Young Adult Panel has 
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D1 Now intervention components 
Support worker
The aim of the support worker in the D1 Now intervention is to provide continuity and build 
relationships between the young adult and their healthcare team. Briefly, the support worker will 
be present at each young adult clinic appointment and ensure that the young adult has set an 
agenda for their appointment and that this agenda is followed through by the healthcare team. The 
support worker will act as an advocate for the young adult on the clinic day and organize a 
multidisciplinary team discussion for each young person at the end of the clinic.  In addition, the 
support worker will communicate with the young adult between clinic appointments on an 
individual basis.  
This pilot study will explore the feasibility of two different strategies of incorporating the support 
worker into the diabetes team: 1) as an external and 2) as an internal support worker. In centres 
allocated to the external support worker arm, the support worker will be hired for the purpose of 
the trial and will be embedded in one intervention site to join the existing diabetes team. In centres 
allocated to the internal support worker arm, this person will be an existing member of the 
diabetes team. The person, a nurse/doctor/dietitian/psychologist, will be upskilled in the role of the 
support worker by the research team and will receive guidance in the role from the external 
support worker. The external support worker only provides support to the internal support worker 
via telephone or email. The external support worker does not attend clinics at the sites allocated to 
the internal support workers. Detailed role specifications and duties of the support worker can be 
found in Appendix S1.
Interactive SMS-based messaging system
Florence or 'Flo' is a software-based SMS text-messaging system that presents an easy-to-use 
friendly interface for young adults and clinicians to interact, with the aim of assisting diabetes self-
management [5]. Text-messaging ‘protocols’ for monitoring a variety of conditions, such as type 2 
diabetes, chronic obstructive pulmonary disease and respiratory failure have been developed [5,6]. 
The D1 Now study team has adapted existing diabetes protocols to Florence for an Irish 
population of young adults with type 1 diabetes. The system operates by responding to health 
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Agenda-setting tool
The third intervention component is an agenda-setting tool that is used by the young adult before 
and within consultations, and aims to improve the interaction between clinician and young adult in 
order to enhance shared decision-making. Through a scoping review of existing agenda-setting 
tools available internationally, the Type 1 Diabetes Consultation (T1C) tool (Health Innovation 
Network) was chosen for inclusion in D1 Now. The T1C tool is specifically designed for the 
management of type 1 diabetes and provides a holistic approach to care planning, bringing 
together a measure for psychological well-being (diabetes distress) as well as clinical results 
(HbA1c and hypoglycaemia unawareness). It enables the clinician to plot the results from the 
psychological and clinical measures on a dartboard-type chart, prompting discussion on the 
relationship between the three measures (Fig. 1). The tool has two parts, the first is completed in 
the waiting room by the young adult and the second is completed jointly by the young adult and 
clinician during the consultation. 
Aims of the D1 Now Pilot study
The aim of the D1 Now pilot study is to gather and analyse the acceptability and feasibility data to 
allow us to (1) refine the D1 Now intervention and (2) determine the feasibility of a definitive 
randomized controlled trial (RCT). Pilot and feasibility studies are not designed to detect a 
treatment effect, and a primary outcome has not been defined in this study. Specifically, the D1 
Now pilot study seeks to determine the following:
 the feasibility and acceptability of the DI Now intervention for young adults living with 
type 1 diabetes and clinicians; 
 the  primary outcome  for a future cluster RCT;
 the feasibility of conducting a health economic assessment of the D1 Now intervention;
 the optimal strategy for recruitment to inform a future cluster RCT;
 the reasons for refusing to participate and attrition;
 the optimal sample size for a future definitive cluster RCT.
This protocol paper follows the reporting guidelines of  the Standard Protocol Items: 











This article is protected by copyright. All rights reserved
Study design
This cluster randomized pilot study has two intervention arms and a control arm.  The intervention 
arms will comprise (1) the D1 Now intervention with an external support worker or (2) the D1 
Now intervention with an internal support worker. These are described below. The control arm 
will consist of usual care. 
Inclusion/exclusion criteria
Table 1 shows the inclusion/exclusion criteria. 
Sample size calculations
As this is a pilot study, a formal sample size calculation is not warranted as one of the aims of the 
study is to generate the estimates needed for a sample size calculation for the definitive trial that 
will follow.  However, we aim to recruit 15–20 young adults in each pilot site. This figure is 
driven mainly by pragmatism. The sample size for the definitive trial will follow the methods 
outlined in Rutterford et al. [8].  In addition to the pilot data that will be collected, data are 
available from a cluster randomized controlled trial (n = 437) of adults with type 1 diabetes, 
approximately 10% of whom  were young adults, attending hospital diabetes clinics in Ireland, 
including information on the likely change in HbA1c at 18-month follow-up, rates of severe 
hypoglycaemia, anxiety and depression, the burden of living with diabetes and quality of life [9].  
These data will be used to generate a prior distribution for the likely change in the primary 
outcome in order to use a Bayesian approach to further inform the sample size proposed for the 
definitive trial, based on the pilot data and assumed prior.
Recruitment
Centre recruitment
In the absence of reliable national data on the prevalence of diabetes, the study team conducted a 
comprehensive scoping exercise of diabetes centres/clinics across Ireland asking them to provide 
estimates of the total number of adults with type 1 diabetes attending their clinic including the 
number between 18 and 25 years. They were also asked if they had a dedicated young adult clinic 
and if they would be interested in taking part in either a pilot and/or definitive intervention trial. 
Centres were contacted up to three times via email to ensure a good response rate. This scoping 
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E-mail invitations will be sent to five of these 12 centres, inviting them to take part in the pilot 
RCT. These five centres will be chosen based on the proximity of centres and ability to compare 
across the Republic of Ireland and Northern Ireland health services. The authors are aware this is a 
non-randomized approach, but pragmatism was required to support the design of the study (i.e. the 
hiring of only one external support worker). If centres do not agree to participate, reasons will be 
recorded and we will move on to the next eligible centre.  
Participant recruitment
The administrator in each diabetes centre will act as a gatekeeper for recruitment. The research 
staff will provide the administrator with inclusion/exclusion criteria and the administrator will help 
identify eligible participants. 
Once identified, the research team will post a letter of invitation and information sheet to 
participants who will be asked to contact the research team if interested in taking part. All 
interested participants will be posted a consent form and asked to return it to the team before the 
trial begins. 
Randomization and intervention procedures
One diabetes centre will be randomized to the D1 Now intervention with one external support 
worker), two diabetes centres will be randomized to the D1 Now intervention with two internal 
support workers (one in each site) and two diabetes centres will be randomized to a usual care 
control arm. Randomization will be conducted by an independent statistician.  
The D1 Now intervention will be delivered at a minimum of three clinic appointments during a 
12-month period. The two intervention arms and control arm are described below. 
D1 Now intervention arm with external support worker
In the D1 Now intervention arm that includes an external support worker, one support worker will 
be embedded in the team for the duration of the pilot trial. 
First clinic 
At the first clinic appointment, the young adult will meet with the support worker. The support 
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support worker will then introduce the agenda-setting tool and ask the participant to complete part 
1 of the tool. After this, the young adult will meet the team and have their consultation using the 
agenda-setting tool. Once the consultation is complete, before leaving, the young adult will meet 
with the support worker who will ask them how their appointment went, provide them with a copy 
of their agenda-setting tool and set them up on Florence. 
The support worker will individualize the Florence set-up/protocols for each young adult, based on 
how many messages they want to receive and what targets they want to set. Participants can 
choose to opt in or opt out of Florence at any time. 
At the end of clinic 1, the support worker will discuss any need for follow-up before the next 
clinic appointment. This follow-up can be in the form of a face-to-face meeting, a telephone call or 
an e-mail in between appointments. The purpose of this follow-up is to: (1) check the use of 
Florence; (2) monitor any actions for the young adult based on their latest appointment; (3) 
remind/change the next clinic appointment if required; and (4) improve engagement. The clinic 
will finish with a multidisciplinary team meeting, during which the support worker alongside the 
diabetes team will discuss each young adult and their care needs. 
Clinics 2 and 3
Subsequent clinic appointments will follow the same procedures. The young adult will first meet 
the support worker and complete the agenda-setting tool. Then the young adult will meet with the 
rest of the team and complete part 2 of the agenda-setting tool and discuss Florence data. The 
appointment will finish with meeting the support worker again and reviewing Florence and any 
need for follow-up before the next appointment. A multidisciplinary team meeting will take place. 
The third clinic appointment will see the support worker discharge the young adult from their care 
and hand over to the team through the final multidisciplinary team meeting. 
D1 Now intervention arm with internal support worker
The D1 Now intervention arm with an internal support worker will follow the same procedures as 
the intervention arm with the external support worker, but the support workers in this arm will be 
members of the existing team. This person, a nurse/doctor/dietitian/psychologist, will be upskilled 
to carry out the role of support worker by the research team and provided with support by the 
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Control arm 
Participants in the control group will receive usual care, which will be described clearly through 
qualitative interviews (see below). 
Staff training 
The support workers, internal and external, will be provided with training on their duties and 
responsibilities by a member of the research team. 
In addition, all staff in the D1 Now intervention arms will be invited to attend D1 Now staff 
training, which will be delivered by a member of the D1 Now research team using a pre-developed 
manual, and will last for approximately 2.5 hours. 
Data collection
Young adult data collection will occur at two time points during the trial: time point 1 (T1) is the 
baseline/clinic appointment 1 (month 0) and time point 2 (T2) is the 12-month follow-up (month 
12). 
All self-report questionnaires for T1 and T2 will be administered to participants in the waiting 
room of their clinic appointment or posted prior to this appointment by the research team. The 
questionnaire will be paper-based. All other quantitative data will be recorded from participants' 
medical charts with the diabetes centre staff acting as gatekeepers to this information with the 
support of research team staff. 
Staff questionnaires
Staff measures will be collected via questionnaire at T1 only. The questionnaire will gather 
demographic and personal information including: profession, length of time working in diabetes 
and employment basis (full-time, part-time and other). 
Young adult type 1 diabetes questionnaires.
The measures listed in Table 2 will be included in the young adult questionnaire. All measures 
will be administered at T1 and T2. The included measures (excluding demographic information) 
are based on a recently published core outcome set among young adults with type 1 diabetes [14]. 
A core outcome set can be defined as an agreed standardized collection of outcomes which should 
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To clarify, a primary outcome has yet to be defined. The results of this study will inform the 
primary outcome in the future definitive trial. 
Fidelity
Fidelity assessment will provide valuable information on the feasibility of the intervention 
implementation, as well as information on the acceptability and usefulness of the fidelity 
assessment procedures which may require adaptation for the definitive RCT. Examples of the 
fidelity assessments can be found in Appendix S3. 
Quantitative evaluation of feasibility and acceptability 
The quantitative evaluation of feasibility and acceptability items listed in Table 3 will be measured 
to inform the protocol for the definitive RCT.
Embedded qualitative component 
A descriptive qualitative approach, as described by Sandelowski [16], will be used to explore the 
perceptions and experiences of young adults living with type 1 diabetes (n =12) and key healthcare 
staff (n =12) of participating in the D1 Now intervention and their views as to the feasibility and 
acceptability of the intervention. In the intervention arms, six young adults will be invited to 
participate in one-to-one interviews at month 6, and six more will be invited to interview at month 
12. These interviews will focus on capturing participants’ views and changes in perceptions as 
they progress through the intervention.  In addition, key healthcare staff facilitating the 
intervention, including consultant endocrinologists (n=3) and support workers (both internal and 
external, n = 3), diabetes nurses (n = 3) and dietitians (n=3) will be invited to participate in one-to-
one interviews at month 12. These interviews will focus on participants’ experiences of delivering 
the intervention and their views on its acceptability and feasibility in practice. Finally, young 
adults (n = 2) and all consultants (n = 2), diabetes nurses (n = 2) and dietitians (n = 2) in the 
control arm will be invited to participate in one-to-one interviews at month 9. The focus of these 
interviews will be to illuminate and describe usual care. The interview and focus group schedule 
can be seen in Appendix S4. Thematic analysis, as outlined by Braun and Clarke [17], will be used 
to analyse the data.  Rigour will be maintained by adhering to the criteria described by Lincoln and 
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A pilot health economic assessment of the D1 Now intervention relative to usual care (control  
arm) will be conducted using preliminary cost-effectiveness analysis and cost–utility analysis. 
Resource use associated with delivery of the D1 Now intervention will be measured and costed. In 
particular, resources relating to the support worker and other healthcare professional time input, 
interactive online tool, agenda-setting tool, educational sessions, consumables, materials, 
equipment and overheads will be measured and costed. In addition, a form detailing the resources 
used by participants, including health service usage, medication usage and private out-of-pocket 
expenses will be completed in the two intervention arms and control group at baseline and 12 
months. For the pilot cost–utility analysis, quality-adjusted life years, which is the preferred 
outcome measure for economic evaluation, will be estimated using data from the EuroQol EQ-5D-
5L instrument at baseline and 12 months [19]. 
Statistical analysis
Descriptive statistics will be presented for all measures. To clarify, this study does not aim to 
determine treatment effect. The aim of the statistical analysis will be to determine the feasibility 
and acceptability of the D1 Now intervention through descriptive statistics, supported by the 
qualitative sub-study. The statistician will be blinded to treatment allocation during analysis. 
As stated previously, a primary outcome has not been defined. A specific objective of this pilot 
study will be to gather information on the quantitative assessments to inform the choice of primary 
outcome in the future definitive RCT. 
Criteria for progression to a full randomized controlled trial
The following predefined stop/go criteria will be used to inform the decision on whether to 
proceed to a full trial: (1) feasibility of recruitment of participants: at least 80% of study target and 
(2) drop-out rate: no more than 30% drop-out of participants at 12 months in each group. These 
criteria will be supplemented by the findings from the qualitative data.
A decision to progress will be decided by the above criteria, as well as discussion with the study 
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Ethics approval has been obtained for all intervention sites. The results of this trial (including 
qualitative and health economic sub-studies) will be published in a peer-reviewed journal. 
Limitations
Our study centres will not be selected completely at random but are likely to be geographically 
close together. We recognize this as a limitation, but a pragmatic approach is needed to ensure the 
design of the D1 Now intervention can be accurately tested in this pilot study. We have opted for  
cluster randomization to avoid contamination of the delivery of the intervention. Many of the sites 
expressing an interest in participating in our pilot have just one endocrinologist, one diabetes 
specialist nurse and one dietitian. A within-centre randomization approach was considered, but 
this would involve staff providing different models of care to intervention and control participants 
which would lead to contamination. 
Protocol registration
The study protocol is registered with the ISRCTN registry [http://www.isrctn.com/login;  
ISRCTN74114336 (Appendix S5)]. 
Funding sources 
This study is funded by the Health Research Board, Ireland under its Definitive Intervention and 
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Figure 1 Agenda setting tool.
Table 1 Inclusion/exclusion criteria
Inclusion criteria for diabetes centres Inclusion criteria for participants
 Dedicated young adult clinic for 
people with type 1 diabetes  
 At least one whole-time equivalent 
diabetologist, diabetes nurse 
specialist and diabetes dietitian 
 Confirmed diagnosis of type 1 
diabetes for more than 12 months
 Age 18–25 years on the date of 
recruitment 
 Access to a mobile phone device 
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Construct to be measured How it will be measured? 
Demographics Self-report: gender, date of birth, education status, occupation, year of 
diagnosis, type of diabetes medication/therapy, comorbidities, and other 
medication
HbA1c Objective: laboratory plasma HbA1c within the last 3 months 
Number of instances of diabetes 
ketoacidosis 
Self-report: this will be obtained from both the medical notes and 
through participant self-report over the past 12 months 
Number of instances of severe 
hypoglycaemia
Self-report: participant self-report over the past 12 months 
Definition: an episode of low blood sugars that you are unable to treat 
yourself, leading to confusion or an inability to think straight 
Clinic engagement This will be operationalized as clinic attendance and will be obtained 
from the clinic administration system over the preceding 12 months 
Diabetes distress Self-report: measured using the Problems Areas in Diabetes-11 scale 
[10] 
Diabetes-related quality of life Self-report: measured using the Audit of Diabetes Dependent Quality of 
Life questionnaire [11]
Diabetes-related self-management Self-report: measured using the Diabetes Self-Management 
Questionnaire [12] 
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Table 3 Quantitative evaluation of feasibility and acceptability 
Methods for quantitative evaluation of feasibility and acceptability
1. Recruitment of diabetes centres will be assessed by documenting the number of 
invitations sent, the number of refusals and number of acceptances 
2. Recruitment of participants will be assessed by documenting the number of 
invitations sent, the number of initial responses, the number of follow-up phone-
calls required, the number of refusals and the number of acceptances 
3. Attrition of participants will be documented at every time point
4. Levels of missing data in returned questionnaires will be reported
5. The comprehensibility and acceptability of all questionnaires will be measured by 
asking participants; how the questionnaires might be improved, and how long they 
took to complete 
6. Engagement with 'Florence' will be readily available and will be reported. 
Engagement will be measured by: number of messages sent per day by Florence, 
number of messages sent per day by the young adult, number of times the Florence 
protocol was changed during the 12-month period
7. The level to which the agenda-setting tool is used, in particular any missing 
sections, will be documented. Specifically, engagement with the tool will be 
captured by its use on the clinic day and reporting which clinical staff engaged with 
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Additional Supporting Information may be found in the online version of this article: 
 
Appendix S1. D1 Now Support Worker Job Spec.
Appendix S2. SPIRIT Checklist.
Appendix S3. Fidelity Assessment Methods and Checklists.
Appendix S4. Interview schedule for embedded qualitative component 
Appendix S5. 
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